COVID-19 patients retain elevated risk of death for at least 18 months after infection
Maybe a complete check up for risk after infection?
Related Articles
FDA Approves Casgevy to Treat Beta-Thalassemia
Casgevy is the first CRISPR-based medicine to be approved for use in the United States for sickle cell disease and beta-thalassemia.
Developing transmissible vaccines for animal infections
Intrinsically safe designs and a staged transparent development process will be essential
Enhanced Health Equity and Timely Diagnoses in Rare Diseases
Cheryl Schwartz discusses Takeda’s report that calls for enhanced health equity and timely diagnosis for rare disease patients
World’s Best Digital Health Companies 2024
Newsweek is partnering with Statista for the inaugural ranking of the World’s Best Digital Health Companies. The list includes 400 companies based in 35 countries
Q&A: Javed Butler, MD, MPH, MBA, discusses the current heart failure medication landscape
Few areas in cardiology are as active as development and implementation of medical therapies for heart failure, and few people are as familiar with that…
Have you or a loved one experienced Ebola virus disease? Your input is needed on a protocol
Be part of a global volunteer community engaged in health evidence work
Dr. B S Ajaikumar, World-renowned Oncologist, Founder and executive chairman of HealthCare Global Enterprises Ltd.(HCG)
Dr. B S Ajaikumar – Celebrated Oncologist & Executive Chairman HCG Cancer Centres. An Indian oncologist and entrepreneur. He is the founder and executive chairman…
How to make exercise changes stick using behavioural change theory with Dr Tim Anstiss. EP#550 | BJSM Podcast
Behaviour change theory and Motivational Interviewing (MI) principles are often an area cited by healthcare professionals as something they would like more training on. The…
Measles spreading in community as cases rise – Public Health Wales
People are warned to look out for early symptoms like a high temperature, cough and red eyes.
